Recall of Omnipod 5 Pods Due to Manufacturing Defect
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Insulet Corporation is recalling 1,240,115 units of Omnipod 5 Pods because of a manufacturing defect that can cause insulin under-delivery, potentially leading to serious health risks like hyperglycemia and diabetic ketoacidosis.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action, a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, cpsc, Devices) map to related alerts in the same area of risk - browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Insulet Corporation is recalling certain Omnipod 5 Pods due to a manufacturing defect that results in an internal soft cannula tear. This defect causes insulin to leak into the Pod instead of being delivered to the user, leading to under-delivery of insulin or, in some cases, complete cessation of delivery.
Which Products Are Affected
The affected products are Omnipod 5 Pods with model/catalog number PT-001662 ASM 5PK Pod STRL OPS G6G7 and UDI-DI: 10385083000527. The recall involves specific lot codes: PH1U02252541, PH1U03282511, PH1U03282522, PH1U03312511, PH1U03312521, PH1U04012511, PH1U04012521, PH1U05052511, PH1U08162531, PH1U08182531, PH1U08182541, PH1U09242511, PH1U09242521, PH1U09242531, PH1U09252521, PH1U09252531, PH1U10152541, PH1U10162531, PH1U10162541, PH1U10172531, PH1U10172541, PH1U10182531, PH1U10182541, PH1U10202511, PH1U10202521, PH1U10202531, PH1U10202541, PH1U10212531, PH1U10212541, PH1U10222531, PH1U10222541, PH1U10232531, PH1U10232541, PH1U10242521, PH1U10242531, PH1U10242541. A total of 1,240,115 units are affected, with nationwide distribution in the United States.
What You Should Do
If a Hazard Alarm is issued by the Pod, users should replace their Pod immediately. Additionally, if the Automated Delivery Restriction (ADR) alert appears, users should check their blood glucose and take appropriate actions as indicated by the system.
Why This Matters
This recall affects users who depend on the device for insulin delivery, as the defect can lead to under-delivery of insulin, resulting in risks of hyperglycemia, diabetic ketoacidosis, and potentially severe health consequences or death.
Source
FDA Recall Number: Z-1797-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.